Conclusion CJC-1295 / Ipamorelin / GHRP-2 is a comprehensive growth hormonesupportive peptide combination designed to enhance natural GH release through multiple physiologic pathways
The pills havent been compared head-to-head in a clinical trial, but in separate studies, the Wegovy pill showed average weight loss of 14% over 64 weeks, compared with 2% for a placebo, while orforglipron showed 11% weight loss over 72 weeks on its highest dose, compared with 2% for the placebo group
doi: 10.1001/jama.2021.23619
Zhou R, Xu Q, Zheng P, Yan L, Zheng J, Dai G
Take control of your health today and experience sustainable weight loss by completing your online evaluation with Klinic
Does PlexusDx offer semaglutide without insurance